SD BioSensor, Inc
137310.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$766.76B
Close$
$614.23
91% downside
Current Fair Value
91% downsideOvervalued by 91% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $766.76 Billion |
|---|---|
| Enterprise Value | $828.04 Billion |
| Dividend Yield | $200.00 (3.12%) |
| Earnings per Share | $-4282.7 |
| Beta | 0.71 |
| Outstanding Shares | 119,619,000 |
Return
| Return on Equity | -30.40% |
|---|---|
| Return on Assets | -25.14% |
| Return on Invested Capital | -5.26% |
Valuation & Multiples
| P/E Ratio | -1.06 |
|---|---|
| PEG | 1.12 |
| Price to Sales | 1.1 |
| Price to Book Ratio | 0.34 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | -5.7 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 16, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SD BioSensor, Inc
656 employees
CEO: Hyo Keun Lee SD Biosensor Inc is an in vitro diagnostic company. It is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The company researches and develops pro...